MAGY Only Makes Sense If You Already Own The Underlying
seekingalpha.com
Want to monitor CNTX?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CNTXcontext therapeutics is dedicated to discovering, acquiring, and developing novel compounds to treat hormone responsive cancers. our lead program is apristor (onapristone xr), an investigational drug for progesterone receptor positive (pr+) breast cancer. up to 70% of breast cancers express progesterone receptor (pr).